Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings

Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings is organized by Radiological Society of North America (RSNA) and will be held during Nov 13, 2017 - Nov 12, 2020. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.

Conference Description :
The goal of the RadioGraphics articles designated as self-assessment CME features and their accompanying tests is to increase understanding of the radiologic characteristics and possible therapeutic options for a variety of pathologic conditions and basic physics principles.

Content Areas :
• Computed Tomography
• Magnetic Resonance Imaging
• Oncologic Imaging

Conference Objectives are :
• Discuss the mechanisms of action of clinically used immune checkpoint inhibitors.
• Distinguish tumor pseudoprogression from true progression in patients undergoing immune checkpoint inhibitor therapy.
• Describe the characteristic imaging findings of immune checkpoint inhibitor-induced colitis, hypophysitis, and pneumonitis.

Additional details will be posted as soon as they are available.